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Abstract 
 
The dorsal raphe nucleus (DRN) is the origin of much of the 5-HT innervation of the 
forebrain. The activity of DRN 5-HT neurons is regulated by a number of receptors 
including GABAA and 5-HT1A inhibitory receptors and by excitatory 
α1-adrenoceptors.  Using in vitro electrophysiological recording we investigated the 
action of progesterone and its metabolite, allopregnanolone on receptor-mediated 
responses of DRN 5-HT neurons. Neither allopregnanolone nor progesterone affected 
the α1-adrenoceptor agonist-induced firing.  Allopregnanolone also had no effect on 
the inhibitory response to 5-HT.  However, allopregnanolone significantly potentiated 
the inhibitory responses to GABAA receptor agonists.  Progesterone did not enhance 
GABAA receptor-meditated inhibitory responses. Thus, the neuroactive metabolite of 
progesterone, allopregnanolone, has the ability to cause potentiation of GABAA-
mediated inhibition of DRN 5-HT neurons.  This effect on 5-HT neurotransmission 
may have relevance for mood disorders commonly associated with reproductive 
hormone events, such as premenstrual dysphoric disorder and postpartum depression.   
 
Keywords: electrophysiology, neurosteroid, rat, serotonin, slice. 
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Introduction 
 
In both rat and man the majority of 5-HT projections in the brain originate from 
neurons in the dorsal raphe nucleus (DRN) (Azmitia and Gannon, 1986; Dahlström 
and Fuxe, 1964; Tork, 1985).  The activity of these DRN neurons, and the consequent 
5-HT release from their forebrain terminals, is controlled by a number of excitatory 
and inhibitory receptors (Piñeyro and Blier, 1999). These include α1-adrenoceptors 
which provide the main excitatory drive (VanderMaelen and Aghajanian, 1983) and 
5-HT1A inhibitory autoreceptors, which inhibit firing (Sprouse and Aghajanian, 1987).  
In addition, GABA has been shown to play an important role in the control of 5-HT 
neurons. Thus, GABAA receptor activation inhibits 5-HT neuronal firing in the DRN 
(Gallager, 1978; Judge et al., 2004a) and 5-HT release in the forebrain (Tao et al., 
1996). Moreover, there is evidence for significant GABAA receptor-mediated tone on 
5-HT neuronal firing and release in vivo (Gervasoni et al., 2000; Levine and Jacobs, 
1992). 
 
5-HT is involved in many physiological functions (Jacobs et al., 1990; Jacobs and 
Fornal, 1991) and dysfunction of 5-HT neurotransmission is thought to underlie mood 
disorders (see Meltzer, 1989). It is well established that mood disorders are more 
prevalent in women than in men (Kessler et al., 1993), suggesting a role for gonadal 
steroids in their aetiology.   This is further supported by the fact that mood disorders 
are commonly associated with reproductive hormone events such as the menstrual 
cycle, pregnancy and the postpartum period (Yonkers et al., 2003).  Interestingly, 
changes in gonadal steroid hormone levels have been shown to affect aspects of 5-HT 
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neurotransmission (Bouali et al., 2003; Lu and Bethea 2002), thus providing a 
mechanism by which reproductive hormone events may lead to changes in mood. 
 
In addition to oestrogen and progesterone, levels of the progesterone metabolite, 
allopregnanolone (3-hydroxy-5-pregnan-20-one; 3,5-tetrahydroprogesterone) 
vary over reproductive hormone events (Girdler et al. 2001; Hill et al., 2001; Wang et 
al. 1996).  Allopregnanolone has been shown to positively modulate GABAA 
receptor-evoked responses in hippocampal and cortical neurons (Mtchedlishvili et al., 
2003; Puia et al., 1993; Stell et al., 2003).  To date there are few data on the effects of 
neuroactive steroids on serotonergic neurons. However, a recent report showed that 
i.c.v. treatment of female rats with allopregnanolone increased the firing rate of DRN 
neurons recorded in vivo (Robichaud and Debonnel, 2004). 
 
The aim of this present study was to examine whether allopregnanolone alters the 
receptor-mediated regulation of 5-HT neurons in the DRN.  In vitro electrophysiology 
was used to determine if allopregnanolone modulated responses to agonists of 
GABAA receptors and 5-HT1A autoreceptors, or affected α1-adrenoceptor driven 
activity. 
 
Method 
 
Experimental Animals 
All experiments had been reviewed and approved by the University of Newcastle 
Ethical Review Panel and were conducted in accordance with the UK Animals 
(Scientific Procedures) Act of 1986 and the European Community Council Directive 
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(86/609/EEC).  All efforts were made to minimize any pain or discomfort of the 
animals. Adult female Hooded-Lister rats (200-300g body weight; Charles River, 
Kent, UK) were group housed under controlled conditions of temperature (22  2 °C) 
and humidity (40%) in a 12 h light/dark cycle (lights on 7 am).  All animals were 
allowed to acclimatise to the holding facilities for at least one week before use.  
Animals, selected at random stages of the oestrous cycle, were decapitated and trunk 
blood collected.   
 
Electrophysiology 
Following decapitation the brain was quickly removed and submerged in oxygenated 
(95% O2-5% CO2) sucrose slush (composition (mM): sucrose 200, HEPES 10, 
MgSO4 7, NaH2PO4 1.2, KCl 2.5, NaHCO3 25, CaCl2 0.5, D-glucose 10, pH 7.4) for 5 
min.  The caudal portion of the brain was then mounted on a block using 
cyanoacrylate glue and submerged in oxygenated sucrose slush in the chamber of a 
vibrating microtome (Vibratome 1000, Vibratome, St.  Louis, USA).  Coronal slices 
(> 3) of the midbrain (400 μm thick) containing the DRN were cut and transferred to a 
Petri dish containing oxygenated artificial cerebrospinal fluid (aCSF) (composition 
(mM): NaCl 124, MgSO4 2.4, KH2PO4 1.25, KCl 3.25, NaHCO3 26, CaCl2 2, D-
glucose 10, pH 7.4).  Slices between bregma -7.6 and -8.3 mm (Paxinos and Watson, 
1998) were trimmed to remove cortical tissue and one slice was transferred to an 
interface perfusion chamber and perfused with aCSF (0.5 ml/min) at 36˚C.  Slices 
were allowed to equilibrate for at least 30 min prior to recording.  The remaining 
slices were maintained in oxygenated aCSF at room temperature until required.  The 
aCSF used during recording contained the α1-adrenoceptor agonist phenylephrine (1 
μM) in order to evoke sustained 5-HT neuronal activity. 
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Extracellular recordings were made from presumed 5-HT neurons in the DRN using 
glass microelectrodes (1.5 mm OD, Clarke Electromedical, Reading, UK; 1-3 MΩ in 
vitro impedance) filled with 2 M NaCl.  Signals were amplified (x1000) with an AC 
differential preamplifier and then fed to a pulse discriminator.  The TTL pulses 
generated were fed to the PC via a computer interface (1401 or micro1401, CED, 
Cambridge, UK) at a sampling rate of 100 Hz. Data were collected using Spike2 
software (version 4, CED, Cambridge, UK).  The microelectrode was advanced 
slowly through the slice (approximately 0.15 mm/min) to decrease the probability of 
missing neurons with slow firing rates.  Neurons were identified as putative 5-HT 
neurons on the basis of their location (in the DRN), basal electrophysiological 
characteristics (regular single spikes 1-2 ms wide with a slow frequency (0.4-3.5 Hz)) 
(Allers and Sharp, 2003; VanderMaelen and Aghajanian, 1983), and their inhibitory 
response to 5-HT (10-100 M).  Following a period of recording of basal firing 
activity, drugs were applied via the perfusion medium at intervals of at least 4 min.  
5-HT and the GABAA receptor agonists, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-
ol hydrochloride (THIP; Gaboxadol) and muscimol, were applied for periods of 2 
min.  The concentration of GABAA receptor agonists producing a submaximal 
response was determined for each neuron. This concentration was used for subsequent 
applications.  Allopregnanolone and progesterone were applied for periods of 3 or 8 
min before and 2 min during reapplication of the GABAA receptor agonist.  The 
agonist was then applied at intervals after the steroid application (10, 30, 60, 90 min) 
for as long as the recording was stable.  Due to potential irreversible effects, 
allopregnanolone or progesterone were only applied once to each slice, unless 
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otherwise stated.  Therefore only one neuron was recorded from each slice and 
between one and three neurons were recorded from each animal. 
 
Materials 
NaCl, MgSO4, KH2PO4, KCl, NaHCO3 and sucrose were purchased from BDH 
Laboratory Supplies.  CaCl2, D-(+)-glucose, HEPES, muscimol, L-phenylephrine 
hydrochloride, progesterone and 5-HT hydrochloride were all purchased from Sigma.  
THIP was purchased from Tocris. Allopregnanolone was purchased from Merck 
Biosciences Ltd.  Allopregnanolone and progesterone were dissolved in ethanol 
before diluting in aCSF, resulting in a final maximum ethanol concentration of 
0.025%.  Other drugs were dissolved in aCSF. 
 
Data analysis and statistics 
Electrophysiological data were analysed offline.  Basal firing was determined in a 120 
s period at the start of the recording and expressed in Hz.  A response to drug 
application was defined as a greater than 5% change from basal over the period of 
application of the drug.  Inhibitory responses were determined as the firing rate in a 
120 s period covering the maximum change in baseline and expressed as a percentage 
change relative to the firing rate in the 120 s immediately before drug application.  
The 120s period was chosen as this was the length of time the slice was perfused with 
the agonist.  Data presented are individual examples or the mean ± SEM.  Differences 
were analysed by paired t-test or repeated measures ANOVA with post hoc paired t-
test analysis. 
 
Serum sample analysis 
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Trunk blood collected at the time of decapitation was allowed to clot on ice before 
samples were centrifuged.  The resulting serum was removed and stored at -20°C until 
assayed.  Samples from 16 animals were assayed for the ovarian sex steroids, 
progesterone and oestradiol using commercially available radioimmunoassay kits 
(immuchem
TM
 coated tube, MP Biomedicals, USA and Diagnostic Systems 
Laboratories, USA, respectively). 
 
 
Results 
 
In the presence of the α1-adrenoceptor agonist phenylephrine (1 μM) presumed 5-HT 
neurons in the DRN fired slowly and regularly (mean basal firing rate: 1.04 ± 0.06 
Hz; range 0.43 – 2.07 Hz; n = 44 neurons from 29 animals) (Fig. 1A).  Application of 
5-HT (10-100 M) inhibited all neurons in a fully reversible manner (mean inhibition 
by 25 M 5-HT: 70.2 ± 5.4%; n = 36) (e.g. Fig. 1A). 
 
The GABAA receptor agonist THIP (2 min application) caused a concentration-
dependent decrease in the firing rate of presumed 5-HT neurons (Fig. 1A).  The THIP 
response was not related to the stage of oestrus at the time the tissue was taken. Thus, 
there was no correlation between the inhibitory responses to THIP (25 μM) and the 
serum levels of either progesterone or oestradiol of individual animals (progesterone: 
r = -0.31, p = 0.24; oestradiol: r = 0.15, p = 0.59; Pearson correlation, n = 16 animals, 
data not shown).   
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The effect of allopregnanolone (5 M) was tested in eleven neurons (nine animals).  
Allopregnanolone (5 M) alone did not affect the basal firing rate after the 5 or 10 
min application (firing rate before allopregnanolone: 0.96 ± 0.14 Hz; 10 min after 
allopregnanolone: 0.95 ± 0.12 Hz; 30 min after allopregnanolone: 1.03 ± 0.13 Hz; 
F2,20 = 2.8, p = 0.08, Repeated measures ANOVA).  However, the inhibitory response 
to THIP was enhanced by allopregnanolone (Fig. 1A,B).  This effect was rapid as the 
response to THIP obtained in the presence of allopregnanolone was potentiated.  
Further 2 min applications of THIP, 10 and 30 min after allopregnanolone application, 
revealed that the potentiation of the THIP response both persisted and increased with 
time (Fig. 1A,B; F3,30 = 14.2, p < 0.001, Repeated measures ANOVA).  In three 
neurons the effect was followed for a prolonged time.  The potentiation of the 
response to THIP was still observed up to 90 min after exposure to allopregnanolone 
(mean inhibition at 90 min: 100 ± 0 % vs. control response: 65.9 ± 9.8 %). Due to this 
persistent effect only one neuron was examined in each slice. 
 
In a further five neurons (four animals), the effect of 1 M and 5 M 
allopregnanolone was examined.  Repeated measures ANOVA over the time course 
of the experiment revealed a significant within subjects effect (F6,24 = 6.0, p<0.01).  
Although the inhibitory response to THIP was not increased during or 10-30 min after 
the application of 1 M allopregnanolone (Fig. 1C; post-hoc paired t-test), in this 
same group of neurons the response was significantly enhanced during, and 10 and 30 
min after, the application of 5 M allopregnanolone (Fig. 1C; p<0.05, post-hoc paired 
t test).   
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The possibility that the allopregnanolone-induced potentiation of the THIP response 
was due to the solvent (0.025% ethanol) or to repeated applications of THIP was 
examined in nine neurones before allopregnanolone or progesterone was applied.  In 
contrast to the effect of allopregnanolone, the ethanol vehicle (0.025%) failed to 
enhance the response to a second application of THIP (p = 0.41, paired t-test; n = 9). 
 
The inhibitory response to the potent GABAA receptor agonist muscimol (0.33 - 1 
µM) was also significantly enhanced by allopregnanolone (Fig. 2A; F6,18 = 7.8, 
p<0.001, Repeated measures ANOVA; n = 4).  Post hoc analysis showed significance 
10 min after the application of 5 µM allopregnanolone (Fig. 2B; p < 0.05, post-hoc 
paired-t-test).  The inhibitory response to muscimol was also significantly enhanced 
during the application of 1 µM allopregnanolone (Fig. 2B; p < 0.05, post-hoc paired-t-
test). 
 
In five neurons (three animals) the response to 5-HT was tested before and after 
allopregnanolone.  While, the inhibitory response to THIP increased (p < 0.05, paired 
t-test; n = 5), allopregnanolone (5 µM) failed to enhance the inhibitory response to 5-
HT (p = 0.95, paired t-test; n = 5) (Fig. 3). 
 
The effect of a 5 min application of progesterone (5 M) on the inhibitory response to 
THIP (10-25 M) was also examined (Fig. 4).  Progesterone alone had no effect on 
the basal firing rate (Fig. 4A; p = 0.15, paired t-test; n = 5).  Likewise, the magnitude 
of the inhibitory response to THIP applied during and 10 min after the progesterone 
application was not different to the control inhibitory response to THIP (Fig. 4A,B; 
F2,8 = 1.3, p = 0.33, Repeated measures ANOVA; n = 5).  
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Discussion 
 
The present study examined whether allopregnanolone or progesterone altered 
receptor-mediated regulation of 5-HT neurons in the DRN.  Acute in vitro application 
of allopregnanolone enhanced the inhibitory response of 5-HT neurons to the GABAA 
receptor agonists, THIP and muscimol. However, allopregnanolone had no effect 
either on the inhibitory response to 5-HT or on the basal firing rate, which was evoked 
by α1-adrenoceptor activation.  In addition, acute application of progesterone had no 
effect on the GABAA response or on α1-adrenoceptor-driven 5-HT neuronal firing. 
Our data show that allopregnanolone selectively enhances GABAA receptor regulation 
of 5-HT neuronal firing. 
 
Identity of neurons recorded 
The DRN neurons recorded in this study fired in a slow and regular pattern and were 
inhibited by 5-HT and so are equivalent to the population of neurons previously 
studied by a number of groups (Abellán et al., 2000; Hanoun et al., 2003; Liu et al., 
2002), including our own (Fairchild et al., 2003; Johnson et al., 2002; Judge et al., 
2004a,b).  Although recent evidence suggests that some non-5-HT neurons in the 
DRN may display the same electrophysiological characteristics as 5-HT neurons and 
are inhibited by 5-HT (Allers and Sharp, 2003; Beck et al., 2004; Kirby et al., 2003), 
we are confident that the vast majority of neurons we recorded in this study are 
serotonergic (see Judge et al., 2004a).  
 
Effect of allopregnanolone on receptor regulation of 5-HT neuronal activity 
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The selective GABAA receptor agonists, THIP and muscimol caused a clear inhibition 
of firing of all 5-HT neurons tested in this study.  We have previously reported that 
the 5-HT neuronal responses to THIP are completely blocked by the GABAA receptor 
antagonist bicuculline (Judge et al., 2004a), indicating the action of THIP is mediated 
by GABAA receptors.  In the present study, the GABAA receptor responses to both 
THIP and muscimol in 5-HT neurons were enhanced by allopregnanolone.  This is 
consistent with previous studies which have shown the positive modulatory effects of 
allopregnanolone on the GABAA receptor responses of neurons of different subtypes 
and from other brain regions (Lambert et al., 1990, Puia et al., 1993). However, whilst 
allopregnanolone has been shown to modulate spontaneous or GABA-induced 
chloride currents (e.g. Fodor et al., 2005; Puia et al., 1993; Zhang and Jackson, 1994) 
or the amplitude of evoked population spikes in CA1 pyramidal neurons (e.g. 
Landgren et al., 1998), to our knowledge this is the first report of single unit activity 
modulation.  This measure is a direct index of neuronal output and the ability of 
allopregnanolone to modulate the GABAergic response of 5-HT neurons will have 
major implications for serotonergic neurotransmission. 
 
Interestingly, allopregnanolone alone did not inhibit DRN 5-HT neuronal firing.  
Several conclusions can be drawn from this observation.  Firstly, the action of 
allopregnanolone is allosteric rather than direct.  There is some evidence that 
allopregnanolone can directly activate GABAA receptors on cultured neurons, 
although the efficacy of allopregnanolone is much lower than that of GABA 
(Callachan et al., 1987; Lambert et al., 1990; Puia et al., 1993).  Secondly, the failure 
of allopregnanolone to alter basal firing suggests that DRN 5-HT neurons in the slice 
preparation are not under tonic GABAA regulation.  This is consistent with our 
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previous observation that the GABAA antagonist bicuculline alone does not increase 
5-HT neuronal firing (Judge et al., 2004a).  However, it should be noted that in vivo 
studies are indicative of significant GABAA receptor-mediated tone regulating 5-HT 
neuronal firing and release (Gervasoni et al., 2000; Levine and Jacobs, 1992).  
Finally, the α1-adreonoceptors, which were tonically activated by phenylephrine in 
order to evoke 5-HT neuronal activity, are not modulated by allopregnanolone. 
 
We have also demonstrated that allopregnanolone does not modulate the inhibitory 
response to 5-HT.  As we have previously shown that under these recording 
conditions the response of DRN 5-HT neurons to 5-HT is mediated by 5-HT1A 
receptors (Johnson et al., 2002), the data indicates that the effect of allopregnanolone 
for GABAA receptors is specific. 
 
Progesterone, at a concentration equivalent to the highest concentration of 
allopregnanolone used, had no effect on either the basal firing rate of DRN 5-HT 
neurons or the response to GABAA receptor-activation.  This suggests that a non-
specific steroid effect (on membrane fluidity, for example) did not underlie the action 
of allopregnanolone.  We also found that although ethanol is a known modulator of 
GABAA receptors (Davies et al., 2003), at the low concentration used here ethanol 
vehicle did not enhance the GABAA receptor response.  Moreover, repeated 
application of THIP failed to potentiate the response of the 5-HT neurons.  Taken 
together, these data indicate a specific enhancement of GABAA receptor mediated 
function by allopregnanolone. 
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The mechanism underlying the potentiation of the GABAA-mediated responses by 
allopregnanolone is likely to be the well established allosteric modulation of the 
GABAA receptor, increasing the binding affinity of receptor agonists and enhancing 
chloride uptake and currents (Majewska, 1990; Zhang and Jackson, 1994). These 
effects are mediated through a site on the receptor distinct from the benzodiazepine 
and barbiturate allosteric sites (Lambert et al., 1990).  In the slice preparation used in 
this study the potentiation persisted (and even increased with time) after a brief 
application of allopregnanolone.  It is unclear if this is a temporal effect or indicates 
that the repeated GABAA receptor activation (with THIP or muscimol), is necessary 
to observe the potentiation.  In our recording system the washout of non-steroidal 
compounds is very quick as evidenced by the profile of the responses to 5-HT and 
THIP (see Fig. 1A, 4A).  However, lipophyllic compounds like allopregnanolone are 
likely to persist in the tissue for longer.  Indeed, the effect of allopregnanolone on 
GABAA receptor activation has been previously described as slowly reversible 
(Poisbeau et al., 1997). Therefore, we may have seen a reversal in the long lasting 
potentiation if it had been possible to record longer than 90 min. 
 
Interestingly, 1 M allopregnanolone enhanced the response to muscimol but not to 
THIP.  The explanation for this is unclear but it is unlikely to be due to differential 
subunit selectivity of the agonists.  Thus, GABAA receptors containing the δ subunit 
are thought to be particularly sensitive to modulation by allopregnanolone (Stell et al., 
2003) and THIP has highest affinity for this type while muscimol does not (Brown et 
al., 2002).  From studies to date the subunit composition of the GABAA receptors on 
5-HT neurones in the DRN is uncertain (Goa et al., 1993; Moragues et al., 2000; 
Rodriguez-Pallares et al., 2001). 
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As DRN 5-HT neurons are reportedly under tonic GABAA receptor inhibition 
in vivo (Gervasoni et al., 2000; Levine and Jacobs, 1992), the effects of 
allopregnanolone on GABAA receptor-mediated inhibition of firing will have 
consequences for 5-HT neurotransmission.  In females, progesterone levels vary 
greatly during the various phases of reproductive life, and evidence suggests that brain 
levels of allopregnanolone mirror these changes (Wang et al., 1996).  At times when 
allopregnanolone levels are high, GABAA receptor-mediated responses may be 
expected to be enhanced and 5-HT neuronal activity may be predicted to be greatly 
diminished.  Consistent with this, a recent in vivo study has reported that GABAA 
receptor inhibition of 5-HT release varies over the oestrous cycle, being greatest 
during proestrus when progesterone, and hence allopregnanolone, levels are highest 
(Felton and Auerbach, 2004).  Similarly, in women, a potential mechanism underlying 
the association between the affective state of premenstrual dysphoric disorder and the 
luteal phase rise in progesterone may include an allopregnanolone-mediated 
potentiation of GABAergic inhibition of serotonergic transmission.   However, not all 
states of elevated progesterone are associated with decreased 5-HT level.  
Progesterone levels are at their highest during pregnancy and although changes in 
5-HT neuronal firing rate have been observed, firing rates are reportedly raised rather 
than lowered during pregnancy (Klink et al., 2002). This apparent discrepancy may be 
explained by evidence from a number of studies, which indicates that chronic 
exposure (2-5 days) to allopregnanolone results in adaptive changes to GABAA 
receptors (Friedman et al., 1993; Yu and Ticku, 1995). Thus, during pregnancy when 
progesterone and allopregnanolone levels are raised for a sustained period, the 
enhancement of GABAA receptor function may be lost.  This may also explain why 
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chronic allopregnanolone treatment (7 days) was shown to increase the firing rate of 
DRN neurons recorded in vivo (Robichaud and Debonnel, 2004).   
 
In summary, the present data demonstrate that the progesterone metabolite, 
allopregnanolone, enhances the inhibitory response of 5-HT neurons to GABAA 
receptor activation. This may have implications for psychiatric disorders associated 
with changes in the levels of the ovarian steroid hormones. 
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Figure 1.  Enhancement of inhibitory responses to the GABAA agonist THIP by 
allopregnanolone.  (A) Example of a recording from an individual 5-HT neuron in the 
DRN showing responses to THIP (50 M) before (control), during and after (10 min, 
30 min and 60 min) the application of allopregnanolone (Allo, 5 M) for 5 min.  
Basal activity was recorded in the continuous presence of the 1-adrenoceptor agonist, 
phenylephrine. THIP was applied for periods of 2 min and allopregnanolone was 
applied for 5 min as indicated by the bars.  Note that recordings have not been 
corrected for the perfusion lag (approximately 2 min).  (B) Mean percentage 
inhibition of 5-HT neuronal firing by THIP (25-50 M) before (control), during and 
30 min after application of allopregnanolone (n = 11).  (C) Concentration-dependent 
effect of allopregnanolone (1 and 5 M) on the potentiation of inhibitory responses to 
THIP. Data are shown as a percentage of the control response to THIP (n = 5) (Mean 
± SEM). * P < 0.05, paired t-test vs. response prior to steroid application (control). 
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Figure 2.  Enhancement of inhibitory responses to the GABAA agonist muscimol by 
allopregnanolone.  (A) Example of a recording from an individual DRN 5-HT neuron 
showing responses to muscimol (Musc, 1 M) before (control), during and after (10 
min, 30 min and 60 min) the application of allopregnanolone (Allo, 1 and 5 M) for 5 
min.  (B) Concentration-dependent effect of allopregnanolone (1 and 5 M) on the 
potentiation of inhibitory responses to muscimol (0.3-1 M). Data are shown as a 
percentage of the control response to muscimol (n = 4) (Mean ± SEM). * P < 0.05, 
paired t-test vs. response prior to steroid application (control). 
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Figure 3.  Allopregnanolone does not potentiate inhibitory responses to 5-HT. (A) 
Example of a recording showing the response of an individual DRN 5-HT neuron to 
5-HT is not enhanced 45 min after allopregnanolone application.  In contrast, the 
response to THIP is greatly potentiated at this time (approximately 45 min after 
application of allopregnanolone, 5 M).  (B) Bar chart showing the percentage 
inhibition of 5-HT neuronal firing by 5-HT (25-50 M) and THIP (10-25 M), before 
(control) and approximately 45 min after the application of allopregnanolone (n = 5).  
(Mean ± SEM).   
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Figure 4.  Progesterone has no effect on the inhibitory responses to the GABAA 
agonist THIP (25-50 M).  (A) Example of a recording from an individual 5-HT 
neuron in the DRN showing responses to THIP before (control), during and after (10 
min) the application of progesterone (Prog, 5 M) for 5 min.  Basal activity was 
recorded in the continuous presence of the 1-adrenoceptor agonist, phenylephrine. 
THIP was applied for periods of 2 min and progesterone was applied for 5 min as 
indicated by the bars.  Note that recordings have not been corrected for the perfusion 
lag (approximately 2 min).  (B) Mean percentage inhibition of 5-HT neuronal firing 
by THIP before (control), during and 10 min after 5 min application of progesterone 
(n = 5) (Mean ± SEM). 
 
